Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The tumor necrosis factor alpha (TNF-a) inhibitors represent one of the major treatment methods for inflammatory diseases. Globally, this drug class is known to be the most successful drugs in the overall pharmaceutical industry. Several conditions such as inflammations, rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and seronegative spondyloarthropathies, can be treated with the help of these drugs.
This report elaborates on the current development of the Tumor Necrosis Factor Alpha Inhibitors industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Janssen Biotech
LG Life Sciences
AbbVie
GlaxoSmithKline
Novartis
Sanofi
Momenta Pharmaceuticals
HanAll Biopharma
AstraZeneca
By Type:
Others
Remicade
Enbrel
Humira
By Application:
Medicine
Others
Scientific Research
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Tumor Necrosis Factor Alpha Inhibitors Market Overview 2018-2029
-
1.1 China Tumor Necrosis Factor Alpha Inhibitors Industry Development Overview
-
1.2 China Tumor Necrosis Factor Alpha Inhibitors Industry Development History
-
1.3 China Tumor Necrosis Factor Alpha Inhibitors Industry Market Size (2018-2029)
-
1.4 China Tumor Necrosis Factor Alpha Inhibitors Market Analysis by Type from Production Side
-
1.4.1 China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.2 China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Remicade (2018-2029)
-
1.4.3 China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Enbrel (2018-2029)
-
1.4.4 China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Humira (2018-2029)
-
1.5 China Tumor Necrosis Factor Alpha Inhibitors Market Analysis by Application from Consumption End
-
1.5.1 China Tumor Necrosis Factor Alpha Inhibitors Sales Volume, Sales Value and Growth Rate of Medicine (2018-2029)
-
1.5.2 China Tumor Necrosis Factor Alpha Inhibitors Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.3 China Tumor Necrosis Factor Alpha Inhibitors Sales Volume, Sales Value and Growth Rate of Scientific Research (2018-2029)
-
1.6 China Tumor Necrosis Factor Alpha Inhibitors Market Analysis by Region
-
1.6.1 North China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
Chapter 2 China Tumor Necrosis Factor Alpha Inhibitors Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Tumor Necrosis Factor Alpha Inhibitors Market Status and Competition at home and abroad in 2023
-
2.2.2 China Tumor Necrosis Factor Alpha Inhibitors Market Status and Competition Analysis in 2023
-
2.2.3 China Tumor Necrosis Factor Alpha Inhibitors Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Tumor Necrosis Factor Alpha Inhibitors Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Tumor Necrosis Factor Alpha Inhibitors Industry Development
Chapter 3 Tumor Necrosis Factor Alpha InhibitorsIndustry Chain Analysis
-
3.1 Tumor Necrosis Factor Alpha Inhibitors Industry Chain
-
3.2 Tumor Necrosis Factor Alpha Inhibitors Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Tumor Necrosis Factor Alpha Inhibitors Market
-
3.3 Tumor Necrosis Factor Alpha Inhibitors Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Tumor Necrosis Factor Alpha Inhibitors Market
Chapter 4 China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
4.1 China Tumor Necrosis Factor Alpha Inhibitors Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Tumor Necrosis Factor Alpha Inhibitors Total Production Volume and Growth Rate from Production Side
-
4.5 China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate, by Type
-
4.5.1 China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Others
-
4.5.2 China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Remicade
-
4.5.3 China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Enbrel
-
4.5.4 China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Humira
Chapter 5 China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Tumor Necrosis Factor Alpha Inhibitors Total Market Size and Growth Rate from Consumption End
-
5.5 China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate, by Application
-
5.5.1 China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate of Medicine
-
5.5.2 China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate of Others
-
5.5.3 China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate of Scientific Research
Chapter 6 China Tumor Necrosis Factor Alpha Inhibitors Market, by Region
-
6.1 China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Production Value, by Region
-
6.2 China Tumor Necrosis Factor Alpha Inhibitors Sales Volume and Sales Value, by Region
Chapter 7 North China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
-
7.1 North China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
7.2 North China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
Chapter 8 Central China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
-
8.1 Central China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
8.2 Central China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
Chapter 9 South China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
-
9.1 South China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
9.2 South China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
Chapter 10 East China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
-
10.1 East China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
10.2 East China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
Chapter 11 Northeast China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
-
11.1 Northeast China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
11.2 Northeast China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
Chapter 12 Southwest China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
-
12.1 Southwest China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
12.2 Southwest China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
Chapter 13 Northwest China Tumor Necrosis Factor Alpha Inhibitors Market Analysis
-
13.1 Northwest China Tumor Necrosis Factor Alpha Inhibitors Market, by Type
-
13.2 Northwest China Tumor Necrosis Factor Alpha Inhibitors Market, by Application
Chapter 14 Company Profiles
-
14.1 Janssen Biotech
-
14.1.1 Janssen Biotech Company Profile
-
14.1.2 Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 LG Life Sciences
-
14.2.1 LG Life Sciences Company Profile
-
14.2.2 LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 AbbVie
-
14.3.1 AbbVie Company Profile
-
14.3.2 AbbVie Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Profile
-
14.4.2 GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Novartis
-
14.5.1 Novartis Company Profile
-
14.5.2 Novartis Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Sanofi
-
14.6.1 Sanofi Company Profile
-
14.6.2 Sanofi Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Momenta Pharmaceuticals
-
14.7.1 Momenta Pharmaceuticals Company Profile
-
14.7.2 Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 HanAll Biopharma
-
14.8.1 HanAll Biopharma Company Profile
-
14.8.2 HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Profile
-
14.9.2 AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Tumor Necrosis Factor Alpha Inhibitors Industry Research Conclusions
-
15.2 Tumor Necrosis Factor Alpha Inhibitors Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Industry Market Size (2018-2029)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Remicade (2018-2029)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Enbrel (2018-2029)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume, Production Value and Growth Rate of Humira (2018-2029)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Sales Volume, Sales Value and Growth Rate of Medicine (2018-2029)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Sales Volume, Sales Value and Growth Rate of Scientific Research (2018-2029)
-
Figure North China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Central China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure South China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure East China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate from 2018-2029
-
Figure Tumor Necrosis Factor Alpha Inhibitors Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Market Share by Type in 2018
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Market Share by Type in 2023
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Remicade (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Enbrel (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume and Growth Rate of Humira (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Market Share by Application in 2018
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Market Share by Application in 2023
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Total Market Size and Growth Rate from Consumption End
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate of Medicine (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate of Others (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Market Size and Growth Rate of Scientific Research (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Region (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Region (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Region (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Production Value by Region (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Production Value Share by Region (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Production Value Share by Region (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Region (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Region (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Region (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Sales Value by Region (2018-2023)
-
Table China Tumor Necrosis Factor Alpha Inhibitors Sales Value Share by Region (2018-2023)
-
Figure China Tumor Necrosis Factor Alpha Inhibitors Sales Value Share by Region (2018-2023)
-
Table North China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Type (2018-2023)
-
Table North China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Figure North China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Table North China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Application (2018-2023)
-
Table North China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure North China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Central China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Type (2018-2023)
-
Table Central China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Central China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Table Central China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Application (2018-2023)
-
Table Central China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Central China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Table South China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Type (2018-2023)
-
Table South China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Figure South China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Table South China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Application (2018-2023)
-
Table South China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure South China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Table East China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Type (2018-2023)
-
Table East China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Figure East China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Table East China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Application (2018-2023)
-
Table East China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure East China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Northeast China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Type (2018-2023)
-
Table Northeast China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Northeast China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Table Northeast China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Application (2018-2023)
-
Table Northeast China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Southwest China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Type (2018-2023)
-
Table Southwest China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Southwest China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Table Southwest China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Application (2018-2023)
-
Table Southwest China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Northwest China Tumor Necrosis Factor Alpha Inhibitors Production Volume by Type (2018-2023)
-
Table Northwest China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Figure Northwest China Tumor Necrosis Factor Alpha Inhibitors Production Volume Share by Type (2018-2023)
-
Table Northwest China Tumor Necrosis Factor Alpha Inhibitors Sales Volume by Application (2018-2023)
-
Table Northwest China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Tumor Necrosis Factor Alpha Inhibitors Sales Volume Share by Application (2018-2023)
-
Table Janssen Biotech Company Profile
-
Table Janssen Biotech Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table LG Life Sciences Company Profile
-
Table LG Life Sciences Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table AbbVie Company Profile
-
Table AbbVie Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table Momenta Pharmaceuticals Company Profile
-
Table Momenta Pharmaceuticals Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table HanAll Biopharma Company Profile
-
Table HanAll Biopharma Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Tumor Necrosis Factor Alpha Inhibitors Revenue, Price and Gross (2018-2023)
-
